Nuclear staining of MTA1 resulted in a weak color reaction in 23.8% of the vulvar carcinoma tissue sections (IRS 1–2), 60.3% showed a moderate (IRS 3, 4, 6), and 7.2% a strong color reaction (IRS 8, 12). This evidence concerns the gene MTA1 and vulvar carcinoma.